155 related articles for article (PubMed ID: 37372450)
21. Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous and non-mucinous colorectal carcinoma.
Foda AA; Palicelli A; Shebl A; Boldorini R; Elnaghi K; ElHawary AK
Indian J Pathol Microbiol; 2019; 62(3):405-412. PubMed ID: 31361228
[TBL] [Abstract][Full Text] [Related]
22. The Prognostic Utilities of DNA Mismatch Repair Status and KRAS and BRAF Mutation in Korean Colorectal Cancer Patients: The KASID Multicenter Study.
Kim TW; Hwang SW; Kim KO; Cha JM; Joo YE; Cho YS
Oncology; 2023; 101(1):49-58. PubMed ID: 36191562
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and predictive role of DNA mismatch repair status in stage II-III colorectal cancer: A systematic review and meta-analysis.
Deng Z; Qin Y; Wang J; Wang G; Lang X; Jiang J; Xie K; Zhang W; Xu H; Shu Y; Zhang Y
Clin Genet; 2020 Jan; 97(1):25-38. PubMed ID: 31432497
[TBL] [Abstract][Full Text] [Related]
24. Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.
Aslanian HR; Burgart LJ; Harrington JJ; Mahoney DW; Zinsmeister AR; Thibodeau SN; Ahlquist DA
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1385-8. PubMed ID: 18639494
[TBL] [Abstract][Full Text] [Related]
25. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
[TBL] [Abstract][Full Text] [Related]
26. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.
Ye JX; Liu Y; Qin Y; Zhong HH; Yi WN; Shi XY
World J Gastroenterol; 2015 Feb; 21(5):1595-605. PubMed ID: 25663779
[TBL] [Abstract][Full Text] [Related]
27. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
[TBL] [Abstract][Full Text] [Related]
28. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review.
Mei WJ; Mi M; Qian J; Xiao N; Yuan Y; Ding PR
Front Immunol; 2022; 13():1019582. PubMed ID: 36618386
[TBL] [Abstract][Full Text] [Related]
30. Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right-sided and left-sided colorectal cancer.
Kanno H; Miyoshi H; Yoshida N; Sudo T; Nakashima K; Takeuchi M; Nomura Y; Seto M; Hisaka T; Tanaka H; Okuda K; Akagi Y; Ohshima K
Cancer Sci; 2020 Aug; 111(8):3032-3044. PubMed ID: 32449240
[TBL] [Abstract][Full Text] [Related]
31. Does tumorigenesis select for or against mutations of the DNA repair-associated genes BRCA2 and MRE11?: considerations from somatic mutations in microsatellite unstable (MSI) gastrointestinal cancers.
van der Heijden MS; Brody JR; Elghalbzouri-Maghrani E; Zdzienicka MZ; Kern SE
BMC Genet; 2006 Jan; 7():3. PubMed ID: 16417627
[TBL] [Abstract][Full Text] [Related]
32. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer.
Ohrling K; Edler D; Hallström M; Ragnhammar P
Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245
[TBL] [Abstract][Full Text] [Related]
33. Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
de Castro E Gloria H; Jesuíno Nogueira L; Bencke Grudzinski P; da Costa Ghignatti PV; Guecheva TN; Motta Leguisamo N; Saffi J
BMC Cancer; 2021 Apr; 21(1):448. PubMed ID: 33888065
[TBL] [Abstract][Full Text] [Related]
34. Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.
O'Brien O; Ryan É; Creavin B; Kelly ME; Mohan HM; Geraghty R; Winter DC; Sheahan K
J Clin Pathol; 2018 Jul; 71(7):631-636. PubMed ID: 29419411
[TBL] [Abstract][Full Text] [Related]
35. Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.
Petrelli F; Ghidini M; Cabiddu M; Pezzica E; Corti D; Turati L; Costanzo A; Varricchio A; Ghidini A; Barni S; Tomasello G
Anticancer Res; 2019 Dec; 39(12):6431-6441. PubMed ID: 31810907
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients.
Ho V; Chung L; Wilkinson K; Lea V; Lim SH; Abubakar A; Ng W; Lee M; Roberts TL; Chua W; Lee CS
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173905
[TBL] [Abstract][Full Text] [Related]
37. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
38. Development of novel models for predicting mismatch repair protein deficiency and relevant disease-free survival in colorectal cancer patients.
Xu Y; Li Y; Zhu Z; Yang J; Tan Y; Wang Y; Xu X
Int J Colorectal Dis; 2022 Jun; 37(6):1449-1464. PubMed ID: 35482069
[TBL] [Abstract][Full Text] [Related]
39. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.
Scarpa M; Ruffolo C; Canal F; Scarpa M; Basato S; Erroi F; Fiorot A; Dall'Agnese L; Pozza A; Porzionato A; Castagliuolo I; Dei Tos AP; Bassi N; Castoro C
Oncotarget; 2015 Dec; 6(41):43472-82. PubMed ID: 26496037
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic features and prognosis of synchronous and metachronous multiple primary colorectal cancer.
Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Su X
Clin Transl Oncol; 2021 Feb; 23(2):335-343. PubMed ID: 32592156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]